TissueForm develops tissue-based biomaterials and implants that replicate extracellular matrix to repair tissue loss.
TissueForm has raised $250K in total funding. The most recent round was Grant. The last funding was announced in May 2023.
TissueForm's investors include Advanced Industries Accelerator (AIA) Program.
TissueForm is headquartered in Boulder, United States.
TissueForm develops tissue-based biomaterials and implants that replicate extracellular matrix to repair tissue loss.
TissueForm is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TissueForm — Funding & Investors." VCBacked, May 18, 2023, https://www.vcbacked.co/company/tissueform. Accessed August 15, 2026.
VCBacked. (2023). TissueForm — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/tissueform
{{cite web |title=TissueForm — Funding & Investors |url=https://www.vcbacked.co/company/tissueform |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated